Health Min: ‘Sovaldi’ suitable treatment for hepatitis C

CAIRO: The Minister of Health Maha Rabat said new medication "Sovaldi" would be a suitable treatment for hepatitis C infection genotype 4 (HCV-4,) which is the strain most present in Egyptian patients.

The new medication was as of late affirmed to treat the infection by the U.S Food and Drug Administration.

Rabat said in a telephone call to al-Mehwar TV on Saturday that this medication treats huge number of patients with hepatitis C, and that the Supreme Committee for Hepatic Viruses in Egypt had applied extraordinary exertion abroad amid the last period to acquire the new pharmaceutical at a suitable value, considering that its expenses can reach U.S. $28,000 for a pack of 28 tablets.

Rabat said that the service's delegates are enthusiastic about affirming that Egypt has high rates of contaminations amid meeting with the World Health Organization, where they will likewise stretch the need of collaboration with universal bodies to encourage the medication's entry to Egypt at a suitable cost.